英伟达支持的AI制药公司Iambic提交美国IPO申请

格隆汇
3 hours ago
英伟达及卡塔尔主权财富基金支持的AI制药公司Iambic Therapeutics于当地时间周一提交了美国首次公开募股(IPO)申请。Iambic成立于2019年(原名Entos),目前正推进利用其AI平台开发的候选药物管线,旨在治疗实体瘤。其进展最快的候选药物IAM1363正在进行早期临床试验,用于治疗乳腺癌等实体瘤。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10